Brought to you by:
Countdown to Capitol Hill: SVS Advocacy and Leadership Conference nears
The Society for Vascular Surgery (SVS) is gearing up for its inaugural Advocacy and Leadership Conference, taking place Sept. 14–16, in Washington, D.C. With less than two months to go, the SVS is encouraging members at all career stages to…
First patient enrolled in AngioDynamics’ AMBITION BTK trial for CLTI
AngioDynamics today announced enrollment of the first patient in AMBITION BTK, a randomized study of the Auryon atherectomy system in patients with below-the-knee chronic limb-threatening ischemia (CLTI). A press release details that AMBITION BTK is a prospective, multicenter, randomized controlled…
Complex PAD skills course registration is open
Registration is now open for the Society for Vascular Surgery (SVS) Complex Peripheral Vascular Interventions (CPVI) Skills Course, taking place from Sept. 20–21 in Rosemont, Illinois. The two-day course will provide participants with hands-on training in the latest techniques and…
First patient treated with InterVene’s Recana thrombectomy catheter system
InterVene announced today that the first patient has been treated with its Recana thrombectomy catheter system for venous in-stent restenosis (ISR). The company shares in a press release that Recana is the first fully integrated mechanical thrombectomy system designed specifically…
SVS highlights landmark paper on functional popliteal artery entrapment syndrome
The Society for Vascular Surgery has highlighted findings from a comprehensive 20-year clinical study that demonstrate treatment of functional popliteal artery entrapment syndrome—particularly in combination with fasciotomy for exertional compartment syndrome—has shown highly effective outcomes, with 82% of patients returning…
MHRA announces UK medical device regulation amends
The Medicines and Healthcare products Regulatory Agency (MHRA) has today announced important new steps to secure access for patients to the latest medical technologies available in Europe and other advanced countries. As well as improving patient access to technologies, the…
‘Parenthood in vascular surgery a personal choice, not a professional deadline’
When is the right time to start a family in vascular surgery? That was a core question posed during the 2025 Vascular Annual Meeting (VAM) in New Orleans (June 4–7) in a dedicated session aimed at tackling issues around parenthood…
New SVS president seeks to enhance communication with members, tighten focus on outcomes
With another Vascular Annual Meeting (VAM) in the books, that means the flag unfurls on a new presidential year. And that means Philadelphia-based vascular surgeon Keith Calligaro, MD, now leads the Society for Vascular Surgery (SVS) as president. And Calligaro,…
SVS launches partnership to help private practice vascular surgeons cut costs
The Society for Vascular Surgery (SVS) has announced a new partnership with group purchasing organization (GPO) Provista in an effort to help provide a cost-slashing benefit to private practice physicians amid ongoing financial pressures in outpatient care. The initiative, unveiled…
Getinge’s iCast covered stent system approved as bridging stent in US
Getinge recently announced that it has received Food and Drug Administration (FDA) premarket approval (PMA) for the iCast covered stent system. The device is now available as a bridging stent for the treatment of patients with aneurysmal disease. Getinge states…